HSBC Holdings’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $139K | Sell |
10,057
-7,701
| -43% | -$107K | ﹤0.01% | 2313 |
|
|
2025
Q1 | $271K | Buy |
17,758
+207
| +1% | +$3.16K | ﹤0.01% | 1994 |
|
|
2024
Q4 | $248K | Buy |
17,551
+4,719
| +37% | +$66.8K | ﹤0.01% | 2189 |
|
|
2024
Q3 | $120K | Sell |
12,832
-1,267
| -9% | -$11.8K | ﹤0.01% | 2380 |
|
|
2024
Q2 | $131K | Sell |
14,099
-492,187
| -97% | -$4.58M | ﹤0.01% | 2317 |
|
|
2024
Q1 | $5.01M | Buy |
506,286
+362,351
| +252% | +$3.58M | ﹤0.01% | 911 |
|
|
2023
Q4 | $465K | Hold |
143,935
| – | – | ﹤0.01% | 1653 |
|
|
2023
Q3 | $764K | Sell |
143,935
-880
| -0.6% | -$4.67K | ﹤0.01% | 1387 |
|
|
2023
Q2 | $1.38M | Buy |
144,815
+23,280
| +19% | +$222K | ﹤0.01% | 1252 |
|
|
2023
Q1 | $1.34M | Sell |
121,535
-4,286
| -3% | -$47.1K | ﹤0.01% | 1311 |
|
|
2022
Q4 | $1.86M | Sell |
125,821
-4,903
| -4% | -$72.5K | ﹤0.01% | 1369 |
|
|
2022
Q3 | $2.5M | Buy |
130,724
+18,967
| +17% | +$363K | ﹤0.01% | 1185 |
|
|
2022
Q2 | $2.38M | Buy |
111,757
+19,769
| +21% | +$422K | ﹤0.01% | 1260 |
|
|
2022
Q1 | $1.77M | Buy |
91,988
+57,465
| +166% | +$1.11M | ﹤0.01% | 1393 |
|
|
2021
Q4 | $810K | Buy |
+34,523
| New | +$810K | ﹤0.01% | 1744 |
|
|
2021
Q1 | – | Sell |
-9,010
| Closed | -$255K | – | 2318 |
|
|
2020
Q4 | $255K | Buy |
+9,010
| New | +$255K | ﹤0.01% | 2240 |
|